Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuwatsuru, R.
Right arrow Articles by Shames, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuwatsuru, R.
Right arrow Articles by Shames, D. M.

Radiology, Vol 202, 131-138, Copyright © 1997 by Radiological Society of North America

ARTICLES

Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents

R Kuwatsuru, RC Brasch, A Muhler, A Mathur, VS Vexler, W Rosenau, J Mintorovitch, Y Berthezene, F Cohen and DM Shames
Department of Radiology, University of California, San Francisco 94143- 0628, USA.

PURPOSE: The potential to define liver tumors at magnetic resonance (MR) imaging was compared with a positive and a negative contrast agent (gadoxetic acid disodium, or gadolinium EOB-DTPA [a hepatocyte-directed agent], and ferumoxides, or superpara-magnetic iron oxide particles [a Kupffer cell-directed agent], respectively) in normal rats and in rats with induced acute hepatitis, fatty liver, or cirrhosis. MATERIALS AND METHODS: Rats with implanted liver adenocarcinomas were divided into four groups: no diffuse liver disease ("normal" [n = 6]) and diffuse liver diseases (induced acute hepatitis [n = 6], fatty liver [n = 6], or cirrhosis [n = 6]). Rats first received gadoxetic acid disodium (50 mumol/kg) and then, 45 minutes later, ferumoxides (10 mumol/kg). Liver signal intensity enhancement and tumor-to-liver contrast-to-noise ratio (C/N) were measured in each group. RESULTS: Mean liver signal intensity enhancement values with gadoxetic acid disodium and ferumoxides were excellent in the normal liver model (176% and -62%, respectively; P < .01) but were significantly reduced in the acute hepatitis model (82% and -36%, respectively). In the fatty livers compared with the normal livers, enhancement with gadoxetic acid disodium was reduced (57%) but with ferumoxides was excellent (-55%). In the cirrhotic livers compared with the normal livers, enhancement with gadoxetic acid disodium (174%) was virtually the same but was impaired with ferumoxides (-43%). CONCLUSION: Hepatic enhancement and tumor-to-liver C/N with either positive or negative liver-enhancing agents can be impaired by the presence of underlying liver disease. Prior knowledge of the type of diffuse liver disease may influence the choice of contrast agent for tumor detection.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
M. Matsuo, M. Kanematsu, K. Itoh, T. Murakami, Y. Maetani, H. Kondo, S. Goshima, N. Kako, H. Hoshi, J. Konishi, et al.
Detection of Malignant Hepatic Tumors with Ferumoxides-Enhanced MRI: Comparison of Five Gradient-Recalled Echo Sequences with Different TEs
Am. J. Roentgenol., January 1, 2004; 182(1): 235 - 242.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. Hirohashi, K. Ueda, H. Uchida, W. Ono, J. Takahama, M. Takewa, S. Kitano, and H. Ohishi
Nondiffuse Fatty Change of the Liver: Discerning Pseudotumor on MR Images Enhanced with Ferumoxides-Initial Observations
Radiology, November 1, 2000; 217(2): 415 - 420.
[Abstract] [Full Text]

Home page
 Am. J. Roentgenol.Home page
G. T. Sica, H. Ji, and P. R. Ros
CT and MR Imaging of Hepatic Metastases
Am. J. Roentgenol., March 1, 2000; 174(3): 691 - 698.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1997 by the Radiological Society of North America.